Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study (Q44278022)

1 December 2017

title

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study (English)

1 reference

1 December 2017

0 references

0 references

4

1 reference

1 December 2017

5

Fink NE

1 reference

1 December 2017

Melamed ML

1

1 reference

1 December 2017

Eustace JA

2

1 reference

1 December 2017

Plantinga L

3

1 reference

1 December 2017

Coresh J

6

1 reference

1 December 2017

Klag MJ

7

1 reference

1 December 2017

Powe NR

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

31 May 2006

1 reference

1 December 2017

1 reference

1 December 2017

volume

70

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

351-357

1 reference

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Cardiovascular complications in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Hypocalcemia, morbidity, and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Phosphate regulation of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Pathophysiology of vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Parathyroid hormone and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Survival following parathyroidectomy among United States dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001542

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001542

1 reference

1 December 2017

1 reference